CAS: 1622848-92-3
![(S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3...](https://static.cymitquimica.com/products/IN/thumb/DA00AQYH.jpg)
(S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide
CAS:1622848-92-3
Fórmula:
C20H19N5O3
Pureza:
99%
Forma y color:
Solid
Peso molecular:
377.3966
Ref: IN-DA00AQYH
| 1mg | 47,00 € | ||
| 5mg | 94,00 € | ||
| 10mg | 131,00 € | ||
| 25mg | 185,00 € | ||
| 50mg | 294,00 € | ||
| 100mg | 623,00 € | ||
| 250mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
GSK2982772
CAS:1622848-92-3
GSK2982772 is an inhibitor of receptor interacting serine/threonine kinase 1 (RIPK1)with IC50 values of 16 …
Fórmula:
C20H19N5O3
Pureza:
99%
Forma y color:
Solid
Peso molecular:
377.4
Ref: TM-T7151
| 1mg | 73,00 € | ||
| 5mg | 145,00 € | ||
| 10mg | 215,00 € | ||
| 25mg | 397,00 € | ||
| 50mg | 591,00 € | ||
| 100mg | 819,00 € | ||
| 1mL*10mM (DMSO) | 123,00 € |
Entrega estimada en Estados Unidos, el Lunes 16 de Diciembre de 2024
![(S)-5-BENZYL-N-(5-METHYL-4-OXO-2,3,4,5-TETRAHYDROBENZO[B][1,4]OXAZEPIN-3-YL)-1H-1,2,4-TRIAZOLE-3...](https://static.cymitquimica.com/products/10/thumb/F539520.jpg)
(S)-5-BENZYL-N-(5-METHYL-4-OXO-2,3,4,5-TETRAHYDROBENZO[B][1,4]OXAZEPIN-3-YL)-1H-1,2,4-TRIAZOLE-3-CARBOXAMIDE
CAS:1622848-92-3
Pureza:
95.0%
Peso molecular:
377.40399169921875
- Éteres
- Amidas
- Heterociclos de 5 miembros
- Triazoles
- Ver más categorías
- Ether e Impurezas
Ref: 10-F539520
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 17 de Diciembre de 2024
GSK 2982772
CAS:1622848-92-3
An ultraselective, first-in-class inhibitor of the Receptor Interacting Protein 1 (RIP1) kinase with nanomolar potency. …
Fórmula:
C20H19N5O3
Pureza:
Min. 95%
Peso molecular:
377.4 g/mol
Ref: 3D-BG166667
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar | ||
| 250mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
